arginine has been researched along with Graft Occlusion, Vascular in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, SY; Chung, MY; Hsieh, MY; Lee, CK; Lin, CC; Wu, CC | 1 |
| Faldynova, L; Karpisek, M; Kovarova, P; Kukla, P; Kusnierova, P; Pleva, L; Plevova, P; Zapletalova, J | 1 |
| Komori, K; Sugimoto, M; Yamanouchi, D | 1 |
| Akdemir, R; Aras, D; Buyukterzi, Z; Cagirci, G; Cay, S; Karakurt, O; Kilic, H; Topaloglu, S; Yazihan, N | 1 |
| Kawamura, M; Masai, T; Matsue, H; Yoshikawa, Y | 1 |
| Kasirajan, K | 1 |
| Ishibashi, T; Maehara, K; Maruyama, Y; Noji, H; Ohkawara, H; Ohwada, T; Sakamoto, T; Shindo, J; Sugimoto, K; Yaoita, H | 1 |
| Butterworth, J; Cannon, MA; Hyland, JM; Riley, RD | 1 |
| Hanaoka, T | 1 |
| Dalen, H; Davies, MG; Hagen, PO; Kim, JH; Makhoul, RG; Svendsen, E | 1 |
| Gloviczki, P; Miller, VM; Rhee, RY | 1 |
| Kambayashi, J; Kawasaki, T; Kim, DI; Sakon, M; Shibuya, T | 1 |
| Blombäck, M; Hamsten, A; Moor, E; Rydén, L; Silveira, A; Tornvall, P; van't Hooft, F; Wiman, B | 1 |
| Collen, D; Fallon, JT; Gold, HK; Jang, IK; Leinbach, RC; Ziskind, AA | 1 |
2 review(s) available for arginine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic beta-Antagonists; Animals; Arginine; Cell Movement; Cell Proliferation; Endothelium, Vascular; Gene Transfer Techniques; Genetic Therapy; Graft Occlusion, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Kinase Inhibitors; rho-Associated Kinases; Transplantation, Autologous; Tunica Intima; Up-Regulation | 2009 |
Outcomes after heparin-induced thrombocytopenia in patients with Propaten vascular grafts.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; California; Coated Materials, Biocompatible; Device Removal; Drug Substitution; Graft Occlusion, Vascular; Heparin; Humans; Ligation; Pipecolic Acids; Prosthesis Design; Reoperation; Risk Assessment; Risk Factors; Sulfonamides; Thrombectomy; Thrombocytopenia; Treatment Outcome | 2012 |
1 trial(s) available for arginine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
Topics: Aged; Amino Acid Substitution; Arginine; Coronary Artery Bypass; Factor V; Glutamine; Graft Occlusion, Vascular; Hemostasis, Surgical; Heterozygote; Humans; Intraoperative Complications; Male; Middle Aged; Point Mutation; Risk Factors; Saphenous Vein | 1998 |
11 other study(ies) available for arginine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.
Topics: Aged; Aged, 80 and over; Amidohydrolases; Arginine; Arteriovenous Shunt, Surgical; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Renal Dialysis; Tunica Intima; Veins | 2019 |
Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.
Topics: Aged; Apolipoproteins D; Apolipoproteins E; Arginine; Biomarkers; Case-Control Studies; Coronary Restenosis; Female; Graft Occlusion, Vascular; Humans; Lipoprotein(a); Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Middle Aged; Percutaneous Coronary Intervention; Peroxidase; Phosphatidylcholine-Sterol O-Acyltransferase; Stents; Vascular Patency | 2015 |
Association between plasma asymmetrical dimethylarginine activity and saphenous vein graft disease in patients with coronary bypass.
Topics: Aged; Arginine; Biomarkers; Coronary Angiography; Coronary Artery Bypass; Enzyme-Linked Immunosorbent Assay; Female; Graft Occlusion, Vascular; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Count; Predictive Value of Tests; Risk Assessment; Risk Factors; Saphenous Vein; Up-Regulation; Vascular Patency | 2010 |
Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Coronary Thrombosis; Female; Graft Occlusion, Vascular; Heparin; Humans; Pipecolic Acids; Stents; Sulfonamides; Thrombocytopenia; Time Factors; Treatment Outcome | 2010 |
Different contribution of apoptosis to the antiproliferative effects of L-arginine, enalapril and losartan on neointimal growth inhibition after balloon arterial injury.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Arginine; Carotid Artery Injuries; Catheterization; Cell Division; Enalapril; Graft Occlusion, Vascular; Losartan; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Up-Regulation | 2002 |
Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery.
Topics: Aged; Angina, Unstable; Antibodies; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Restenosis; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Heparin; Humans; Male; Myocardial Revascularization; Partial Thromboplastin Time; Pipecolic Acids; Reoperation; Stents; Sulfonamides; Treatment Failure | 2004 |
[An experimental study of arterial graft implantation--the effects of an anti-thrombin agent, argatroban, and an anti-platelet agent, clopidogrel (SR 25990 C) on the inner capsule].
Topics: Angioscopy; Animals; Antithrombins; Aorta, Abdominal; Arginine; Blood Coagulation; Blood Vessel Prosthesis; Clopidogrel; Dogs; Fibrinolysis; Graft Occlusion, Vascular; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Ticlopidine | 1994 |
Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Topics: Animals; Arginine; Carotid Artery, Common; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Nitric Oxide; Rabbits; Tunica Intima; Vasoconstriction; Vasodilation | 1994 |
An arginine analog inhibits responses of both the endothelium and smooth muscle of canine in situ vein grafts.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Brimonidine Tartrate; Calcimycin; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Femoral Artery; Femoral Vein; Graft Occlusion, Vascular; Ionophores; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Organ Culture Techniques; Quinoxalines; Vascular Resistance; Veins | 1997 |
In vivo evaluation of DX-9065a, a synthetic factor Xa inhibitor, in experimental vein graft.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Blood Vessel Prosthesis; Disease Models, Animal; Factor Xa Inhibitors; Graft Occlusion, Vascular; Heparin; Male; Microscopy, Electron, Scanning; Naphthalenes; Pipecolic Acids; Propionates; Rabbits; Sulfonamides; Thrombosis | 1996 |
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Bleeding Time; Blood Platelets; Femoral Artery; Graft Occlusion, Vascular; Heparin; In Vitro Techniques; Injections, Intra-Arterial; Injections, Intravenous; Pipecolic Acids; Rabbits; Regional Blood Flow; Sulfonamides; Thrombosis | 1990 |